Theranexus SA (ALTHX) - Total Liabilities

Latest as of December 2025: €7.64 Million EUR ≈ $8.94 Million USD

Based on the latest financial reports, Theranexus SA (ALTHX) has total liabilities worth €7.64 Million EUR (≈ $8.94 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Theranexus SA to track the company's year-over-year net asset growth rate.

Theranexus SA - Total Liabilities Trend (2015–2025)

This chart illustrates how Theranexus SA's total liabilities have evolved over time, based on quarterly financial data. See ALTHX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Theranexus SA Competitors by Total Liabilities

The table below lists competitors of Theranexus SA ranked by their total liabilities.

Company	Country	Total Liabilities
Information and Communication Networks Public Company Limited BK:ICN	Thailand	฿1.23 Billion
Romerike Sparebank OL:ROMER	Norway	Nkr16.57 Billion
Lay Hong Bhd KLSE:9385	Malaysia	RM469.16 Million
Derluks Yatirim Holding AS IS:DERHL	Turkey	TL3.07 Billion
FTC Solar Inc NASDAQ:FTCI	USA	$104.00 Million
Metagenomi, Inc. Common Stock NASDAQ:MGX	USA	$59.17 Million
TJGC Group Limited NASDAQ:TJGC	USA	$2.18 Million
Impact BioMedical, Inc. NYSE MKT:IBO	USA	$27.06 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Theranexus SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Theranexus SA.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.72	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Theranexus SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Theranexus SA (2015–2025)

The table below shows the annual total liabilities of Theranexus SA from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	€7.64 Million ≈ $8.94 Million	+41.64%
2024-12-31	€5.40 Million ≈ $6.31 Million	+7.58%
2023-12-31	€5.02 Million ≈ $5.86 Million	-20.70%
2022-12-31	€6.33 Million ≈ $7.40 Million	-5.70%
2021-12-31	€6.71 Million ≈ $7.84 Million	-6.67%
2020-12-31	€7.19 Million ≈ $8.40 Million	+33.24%
2019-12-31	€5.39 Million ≈ $6.31 Million	-0.83%
2018-12-31	€5.44 Million ≈ $6.36 Million	+226.73%
2017-12-31	€1.66 Million ≈ $1.95 Million	-40.35%
2016-12-31	€2.79 Million ≈ $3.26 Million	+165.91%
2015-12-31	€1.05 Million ≈ $1.23 Million	--

About Theranexus SA

PA:ALTHX France Biotechnology

Market Cap

$72.09 Million

€61.67 Million EUR

Market Cap Rank

#22193 Global

#348 in France

Share Price

€4.27

Change (1 day)

-0.70%

52-Week Range

€1.57 - €4.37

All Time High

€22.70